Janney Montgomery Scott’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Janney Montgomery Scott's AQST Position: Q3 2026 in Review
Janney Montgomery Scott increased its Aquestive Therapeutics (AQST) stake by 0.18% in Q3 2026, buying an estimated $8.89K and bringing the position to 1,108,160 shares worth $5.13M. The position accounts for 0.01% of the portfolio, ranked #972.
Janney Montgomery Scott first reported a position in AQST in Q1 2024 and has held it in 11 quarters since. The position peaked at $7.06M in Q4 2025. 190 funds tracked by Wall St. Rank hold AQST as of Q3 2026.
- Janney Montgomery Scott held 1,108,160 shares of Aquestive Therapeutics worth $5.13M as of Q3 2026.
- Janney Montgomery Scott bought 2,000 Aquestive Therapeutics shares in Q3 2026, an estimated $8.89K.
- Aquestive Therapeutics made up 0.01% of Janney Montgomery Scott's portfolio in Q3 2026, its #972 holding.
- Janney Montgomery Scott first reported a position in Aquestive Therapeutics in Q1 2024 and has held it in 11 quarters since.
- Janney Montgomery Scott's Aquestive Therapeutics position peaked at $7.06M in Q4 2025.
- 190 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2026.
Based on Janney Montgomery Scott's 13F filing for Q3 2026, filed 12 Nov 2026.